To assist providers in managing high-dollar inventory, McKesson has introduced radio frequency identification (RFID) cabinets as part of McKesson Point of Use Supply. The vendor-neutral cabinets now integrate with clinical workflow to better support patient safety while making it easier for providers to monitor inventory and manage expenses, particularly in high-cost specialty areas like cardiology, radiology and operating room (OR) departments.
GE Healthcare has initiated a Class I recall of all its nuclear imaging systems and called for its systems to not be operated until the vendor can inspect the scanner. The recall follows the death of a patient after a portion of the scanner fell onto the patient during the scan on an Infinia Hawkeye 4 system at a VA medical center facility in the United States.
There is a “new normal” for the global medical device market where financial constraints increasingly impact both treatment and purchasing decision-making. As a result, companies develop products that demonstrate improved clinical outcomes and continue to provide services that raise the quality and efficiency of healthcare delivery in an increasingly resource-constrained environment.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) clearance, CE mark and Japan PMDA approval for its OptiCross Coronary Imaging Catheter and has launched the device in the United States and Europe. A launch in Japan is planned for later this month. OptiCross, a next generation intravascular ultrasound (IVUS) catheter, offers better deliverability and higher resolution imaging to facilitate complex coronary procedures.
Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been shown to be superior to single photon emission computed tomography (SPECT). Nevertheless, widespread clinical use of PET MPI has been limited by the currently available PET myocardial perfusion tracers.
Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, new information systems that leverage natural language and changing market conditions.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Heart IT has released version 8 of its flagship products: WebPax picture archive and communications system (PACS) and remote viewing system, Universal Viewer.
Merck announced that the New Drug Application (NDA) for its investigational anti-thrombotic medicine, vorapaxar, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).
July 25, 2013 — The 2013 ESC (European Society of Cardiology) Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, developed in collaboration with the European Heart Rhythm Association (EHRA), have created a new classification system for bradyarrhythmias according to mechanisms rather than aetiology.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Sanford Aberdeen Medical Center in Aberdeen, S.D. became the first hospital to perform a robotic angioplasty for a patient with an acute heart attack, achieving a far better door-to-balloon time than the national standard. Interventional cardiologist Puneet Sharma, performed the percutaneous coronary intervention (PCI) to treat a patient that had experienced a heart attack and presented to the Sanford Aberdeen emergency department. Utilizing the U.S. Food and Drug Administration (FDA)-cleared CorPath System, Sharma was able to perform the robotic-assisted angioplasty procedure and restore blood flow to the patient’s heart within 68 minutes of their arrival.
July 24, 2013 — St. Jude Medical Inc. announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and launch of the Accent MRI pacemaker and the Tendril MRI lead.
Infraredx Inc. announced the publication of key data supporting the ability of its TVC imaging system to detect lipid core plaque in patients with ST-segment elevation myocardial infarction (STEMI). The study, published in JACC: “Cardiovascular Interventions,” details the identification of a specific cholesterol signature by near-infrared spectroscopy (NIRS) at the site of the culprit lesions causing STEMI, a dangerous type of heart attack. While the TVC Imaging System has been used in more than 3,000 patients worldwide, the present clinical study is the first report of its use in a consecutive series of STEMI patients.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 23, 2013 — BioVentrix, known for the Less Invasive Ventricular Enhancement (LIVE) procedure for the treatment of heart failure, announced publication of baseline and 12-month comparative data demonstrating the durability of its Revivent myocardial anchoring system in the first 11 patients treated with the device.
IMRIS has announced U.S. Food and Drug Administration (FDA) 510K clearance to market VISIUS iCT, the first and only ceiling-mounted intraoperative computed tomography (iCT) on the market.
Zoll Medical Corp has announced that survival from one of the leading causes of death in the United States, out-of-hospital cardiac arrest, more than doubled from 26 percent to 56 percent when paramedics in Mesa, Ariz., utilized Zoll’s cardiopulmonary resuscitation (CPR) feedback technology in combination with scenario-based training. The findings also showed that high-quality CPR was associated with significantly improved neurologically intact survival.